1. Home
  2. OSPN vs AVBP Comparison

OSPN vs AVBP Comparison

Compare OSPN & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSPN
  • AVBP
  • Stock Information
  • Founded
  • OSPN 1991
  • AVBP 2021
  • Country
  • OSPN United States
  • AVBP United States
  • Employees
  • OSPN N/A
  • AVBP N/A
  • Industry
  • OSPN EDP Services
  • AVBP
  • Sector
  • OSPN Technology
  • AVBP
  • Exchange
  • OSPN Nasdaq
  • AVBP NYSE
  • Market Cap
  • OSPN 549.4M
  • AVBP 617.4M
  • IPO Year
  • OSPN 1998
  • AVBP 2024
  • Fundamental
  • Price
  • OSPN $15.78
  • AVBP $20.15
  • Analyst Decision
  • OSPN Strong Buy
  • AVBP Strong Buy
  • Analyst Count
  • OSPN 4
  • AVBP 6
  • Target Price
  • OSPN $17.13
  • AVBP $39.00
  • AVG Volume (30 Days)
  • OSPN 335.0K
  • AVBP 158.1K
  • Earning Date
  • OSPN 05-01-2025
  • AVBP 05-20-2025
  • Dividend Yield
  • OSPN 1.52%
  • AVBP N/A
  • EPS Growth
  • OSPN N/A
  • AVBP N/A
  • EPS
  • OSPN 1.48
  • AVBP N/A
  • Revenue
  • OSPN $241,702,000.00
  • AVBP N/A
  • Revenue This Year
  • OSPN $4.31
  • AVBP $63.13
  • Revenue Next Year
  • OSPN $5.31
  • AVBP N/A
  • P/E Ratio
  • OSPN $10.64
  • AVBP N/A
  • Revenue Growth
  • OSPN N/A
  • AVBP N/A
  • 52 Week Low
  • OSPN $11.70
  • AVBP $15.47
  • 52 Week High
  • OSPN $20.36
  • AVBP $36.37
  • Technical
  • Relative Strength Index (RSI)
  • OSPN 58.22
  • AVBP 51.13
  • Support Level
  • OSPN $14.55
  • AVBP $18.84
  • Resistance Level
  • OSPN $16.00
  • AVBP $21.79
  • Average True Range (ATR)
  • OSPN 0.58
  • AVBP 1.12
  • MACD
  • OSPN 0.16
  • AVBP 0.00
  • Stochastic Oscillator
  • OSPN 70.63
  • AVBP 44.50

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: